查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095728

外部二氧化碳去除設備市場－全球市場預測（2026-2032年）

Extracorporeal CO2 Removal Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，外部二氧化碳去除系統的市場規模將成長至 2.8705 億美元，複合年成長率為 8.73%。

主要市場統計數據
基準年 2025 1.5968億美元
預計年份：2026年 1.7885億美元
預測年份 2032 2.8705億美元
複合年成長率 (%) 8.73%

體外二氧化碳清除系統正逐漸成為高階呼吸輔助的關鍵支援工具，特別適用於急性慢性阻塞性肺病以及急性呼吸窘迫症候群（ARDS）患者，因為在這些情況下，傳統的機械通氣可能會加重肺損傷。這些系統利用膜式氣體交換技術，透過體外血液循環清除二氧化碳，使臨床醫生能夠降低機械通氣強度，並支持肺部保護性或超保護性通氣策略。 COPD（慢性阻塞性肺病）在全球造成的沉重負擔，以及重症監護病房（ICU）中持續存在的嚴重呼吸道感染疾病、難治性高碳酸血症和長期機械呼吸系統護理需求，進一步凸顯了體外二氧化碳清除加護病房的臨床意義。低流量體外支持、血液相容性膜的改進、抗凝血管理、血管通路以及與重症監護工作流程的整合等方面的臨床關注度不斷提高，推動了該領域的發展。儘管體外二氧化碳清除技術的實施仍然嚴重依賴訓練有素的多學科團隊、報銷方案、安全證據和醫院基礎設施，但隨著醫療保健系統尋求為複雜的、依賴重症監護的患者群體提供更精確、侵入性更小的呼吸支持方案，體外二氧化碳清除技術繼續引起人們的關注。

體外二氧化碳清除領域的變革性變化

體外二氧化碳清除裝置的格局正在轉變，其應用正從挽救生命的體外支持轉向旨在減輕人工呼吸器相關性肺損傷的靶向呼吸系統護理。裝置創新正朝著減少預充量、提高膜氧合性能、簡化迴路、壓力和流量監測以及增強生物相容性的方向發展，以減少凝血、出血、溶血和發炎併發症。隨著病患選擇、介入時機、抗凝血策略、血管通路方法、介入強化標準和人工呼吸器撤機路徑的不斷完善，加護病房（ICU）的臨床方案也不斷發展。另一個顯著的變化是呼吸護理、腎臟病學、灌注治療和體外生命支持等領域專業知識的融合，一些平台和護理模式與熟悉的腎臟替代療法流程相契合。監管審查和證據收集標準日益嚴格，要求醫院在廣泛採用體外受精技術前，必須提供療效數據、易用性證據、人因工程檢驗以及清晰的風險收益分析。同時，儘管疫情期間對重症監護基礎設施的投資提高了人們對體外受精技術的認知，但其應用仍然因地區、培訓資源、保險報銷支持以及醫療機構經驗的不同而存在很大差異。

人工智慧對外部二氧化碳去除的累積影響

人工智慧正開始影響體外二氧化碳清除，其角色並非取代臨床醫師的判斷，而是輔助決策、監測設備、進行預測分析並最佳化工作流程。在重症監護環境中，人工智慧模型可透過分析血液氣體、呼吸器設定、血流動力學、人工呼吸器指標、影像學結果和合併症情況，幫助識別存在人工呼吸器相關性肺損傷、難治性高碳酸血症、機械通氣時間延長或酸鹼平衡快速惡化風險的患者。當與體外平台和醫院資訊系統整合時，先進的分析功能有助於早期發現迴路凝血風險、膜性能下降、抗凝血治療不穩定、壓力變化、氣體交換效率降低或血流動力學惡化。人工智慧還可以透過對掃氣設定、血流參數、動脈血二氧化碳濃度、酸鹼狀態和肺保護性通氣目標的偏差發出警報，來促進方案的依從性。然而，其累積效應取決於檢驗的臨床資料集、互通性、透明的演算法、網路安全措施、臨床醫生監督以及針對不同患者群體的謹慎偏差緩解。其最直接的價值在於為重症監護醫師、灌注技師、呼吸治療師、腎臟科醫生和護士提供即時訊息，從而提高安全性、減輕認知負擔並規範複雜的體外呼吸支持操作。

亞太地區、北美地區、拉丁美洲地區、歐洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區慢性呼吸系統疾病負擔沉重，城市人口密度高，空氣污染嚴重，且三級醫療基礎設施不斷完善，因此，體外二氧化碳清除療法在先進醫院中具有重要的臨床意義，尤其是在中國、日本、韓國、澳洲和印度。北美地區擁有成熟的重症監護網路、成熟的體外生命支持技術、學術型重症監護計畫以及注重安全證據、品質系統和臨床結果的法規環境，這些都支持在專業機構中系統性地應用該療法。在拉丁美洲，該療法的應用主要集中在主要大都會圈的醫院。這些醫院面臨著日益嚴重的呼吸系統疾病負擔和重症監護現代化改造的雙重挑戰，同時也面臨保險報銷、專科醫生培訓、生物醫學工程支持以及一次性耗材供應等方面的限制。歐洲則擁有強大的重症監護研究網路、成熟的呼吸醫學技術以及統一的醫療設備法規，這些法規更加重視臨床評估、上市後監測、風險管理和品管。在中東，重症患者基礎設施、醫療旅遊中心以及政府主導的醫療現代化投資正在取得進展，其中以先進的三級和四級醫療機構的實施最為顯著。非洲的情況仍參差不齊，除主要轉診醫療機構外，其他地區的醫療服務取得管道有限。然而，呼吸道感染疾病、慢性阻塞性肺病、結核病相關肺病和嚴重負擔的日益加重，凸顯了大規模體外二氧化碳清除技術推廣應用所需的可擴展培訓、生物醫學工程能力、氧氣和血氣分析基礎設施以及可靠的供應鏈。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東協地區，體外碳清除的重要性與重症監護投入的增加、非傳染性呼吸系統疾病的上升、持續的空氣品質挑戰以及發達都市區醫院與資源匱乏地區之間醫療資源分配不均等問題密切相關。海灣合作理事會（GCC）國家由於其高額的醫療費用支出、現代化的醫院基礎設施、對專業重症監護服務的戰略性投資以及訓練有素的多學科團隊，在實施先進的體外呼吸支持方面具有相對優勢。歐盟為醫療設備品質、臨床證據和跨境研究合作提供了一個系統的環境，其實施受到醫療設備法規、醫療技術評估、採購審查和醫院層面的成本效益評估的限制。金磚國家雖然面臨著沉重的呼吸系統疾病負擔，並且正在不斷擴大三級醫療服務能力，但由於報銷制度、本地製造能力、專業培訓、監管管道和公共部門採購等方面的差異，其實施情況存在顯著差異。儘管七國集團（G7）國家憑藉其先進的重症監護基礎設施、完善的臨床研究體系、呼吸醫學專業知識以及強大的多學科體外呼吸支援團隊，在部署方面普遍做好了充分準備，但支付方的評估和安全性證據仍然至關重要。北約成員國與高所得國家的醫療保健體系高度重合，因此也擁有先進的生命救援和緊急醫療能力。同時，緊急準備、創傷護理和軍事醫學領域的優先事項可能會進一步提升人們對高度便攜、可靠且可快速部署的體外呼吸支援技術在嚴重呼吸衰竭情況下的應用需求。

對主要體外二氧化碳清除市場關鍵國家的深入分析。

美國擁有先進的重症監護體系、高慢性阻塞性肺病（COPD）患病率、大規模的大學醫院網路以及眾多精通體外生命支持的專科中心，因此體外二氧化碳清除技術的應用與該國的發展高度相關。同時，加拿大的推廣應用受到公共資助的醫療保健評估、區域轉診網路以及對循證ICU護理的重視的影響。墨西哥和巴西呼吸系統疾病負擔沉重，且擁有強大的三級醫療能力，但相關服務主要集中在處理高度複雜病例的醫院，培訓、保險報銷、轉診途徑和耗材供應等因素影響著這些醫院的實際應用。在歐洲，英國、德國、法國、義大利和西班牙擁有高度發展的重症監護和呼吸醫學體系，其中德國和法國尤其擁有完善的醫院基礎設施和臨床研究能力，而英國強調基於指南的推廣應用、國家臨床管治和醫療技術評估。俄羅斯擁有能夠處理複雜重症監護的先進三級醫療中心，但地理遼闊和基礎設施不平衡限制了其服務範圍。中國正迅速擴大重症監護能力，隨著慢性阻塞性肺病和空氣污染相關呼吸系統疾病負擔日益加重，各大醫院的臨床證據也日益充分。印度面臨沉重的呼吸系統疾病負擔，但重症監護病房的可近性參差不齊，因此成本效益、培訓和可擴展的服務模式至關重要。日本、韓國和澳洲擁有成熟的醫院系統、完善的生物醫學標準、經驗豐富的重症監護團隊以及成熟的呼吸支持方法，能夠支持在具備完善的患者篩選、抗凝血管理和安全規程的專業機構中選擇性地部署重症監護服務。

為行業領導者提供的實用建議

產業領導者應優先考慮可靠的臨床證據、便捷易用的操作以及以安全為中心的設計，以加速體外二氧化碳清除裝置的合理部署。產品開發應著重於降低出血和血栓形成的風險、簡化迴路設定、提高膜的耐用性、最大限度地減少血液損傷、增強壓力和流量監測，以及與ICU資訊系統和人工呼吸器資料流整合。商業策略應根據醫院的準備情況量身定做，而非大規模推廣，目標客戶應是擁有訓練有素的呼吸機、灌注、腎臟、血管通路和體外生命支持團隊的專業重症監護中心。教育計畫應包括基於模擬的訓練、抗凝血方案、插管和血管通路指導、故障排除程序、警報管理以及多學科能力架構。領導者還應投資於真實世界證據註冊、上市後監測、人因工程研究和可互通的資料收集，以證明其安全性、臨床效用和工作流程價值。在新興地區，與醫院、專業協會和公共衛生利益相關人員夥伴關係有助於應對諸如培訓、維護能力、耗材供應和供應鏈可靠性方面的差距等挑戰。將其明確定位為肺保護性通氣的輔助手段，而非傳統治療的完全替代品，有助於傳遞具有臨床說服力的訊息，並促進其永續應用。

調查方法

體外二氧化碳清除裝置的評估調查方法是基於三角測量法，該方法結合了檢驗的二手資料、臨床文獻、監管文件、醫院實踐模式以及專家對重症監護趨勢的解讀。證據來源包括關於體外二氧化碳清除、呼吸衰竭管理、慢性阻塞性肺病（COPD）和急性呼吸窘迫症候群（ARDS）治療、通氣策略、抗凝血治療相關併發症、裝置安全性、膜式氣體交換以及與ICU工作流程整合等方面的同行評審研究。來自經認證的國內和國際機構的公共衛生數據被用於提供關於呼吸系統疾病負擔、重症監護需求、空氣污染暴露、人口壓力和區域醫療保健能力的背景資訊。監管和標準資訊來源。透過比較來自多個資訊來源類別包括臨床指南、系統綜述、基於註冊的觀察性數據、醫療保健系統報告、健康技術政策文件和重症監護學會出版刊物。本調查方法有意避免估算市場規模、計算市場佔有率或預測市場佔有率。相反，它側重於基於證據的定性評估，分析技術採納的促進因素和障礙、區域採納準備情況以及對相關人員的策略影響。

結論

體外二氧化碳清除裝置在先進呼吸支持的發展中佔有重要的戰略地位。隨著重症監護團隊在應對嚴重高碳酸血症和複雜呼吸衰竭的同時，努力減輕人工呼吸器相關性損傷，體外二氧化碳清除裝置的重要性日益凸顯。此領域的進步得益於膜技術、迴路設計、監測、臨床方案、血管通路、抗凝血治療實踐以及多學科培訓等方面的改進，而人工智慧（AI）的運用則進一步提升了患者篩選、安全監測和操作一致性。區域部署不僅受疾病負擔的影響，還取決於專業ICU基礎設施的可用性、明確的保險報銷、監管的可靠性、可靠的耗材供應以及經驗豐富的臨床團隊。擁有完善重症監護網路的國家和地區在選擇性部署方面具有優勢，而新興地區則需要可擴展的培訓、服務模式、生物醫學工程支援以及供應鏈的韌性。對於產業相關人員，長期成功取決於產生可靠的臨床證據、設計更安全、更簡單的系統，以及使科技與實際的重症監護工作流程相契合。隨著醫院不斷完善肺部保護策略，體外二氧化碳清除技術可望繼續成為精準重症監護和先進呼吸醫學領域備受關注的技術。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：外部二氧化碳去除設備市場：依產品分類

  • 膜肺系統
    • 低流量濾芯
    • 高通量墨盒
  • 模組化 ECCO2R 套件
    • 腎臟平台適配器
    • ECMO平台適配器
  • 主機
  • 免洗治療包

第8章：外部二氧化碳去除設備市場：依技術分類

  • 幫浦驅動靜脈
    • 雙腔靜脈型
    • 單導管靜脈型
  • 無動脈和靜脈泵
  • 基於血液透析的清除
  • 混合氣體交換

第9章：外部二氧化碳去除設備市場：依處理能力等級分類

  • 低流量去除
  • 中流去除
  • 高流量去除

第10章：外部二氧化碳去除裝置市場：依運作模式分類

  • 自動化系統
  • 手動系統

第11章：外部二氧化碳去除設備市場：按應用領域分類

  • 急性呼吸窘迫症候群
  • 肺移植前的過渡治療
  • 慢性阻塞性肺病
  • 術後呼吸支持
  • 高碳酸血症誘發的呼吸衰竭

第12章：外部二氧化碳去除設備市場：依最終用戶分類

  • 門診手術中心
  • 居家醫療
  • 醫院
  • 專科診所

第13章：外部二氧化碳去除設備市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：外部二氧化碳去除設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：外部二氧化碳去除設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Aferetica Srl
  • Baxter International Inc.
  • Braile Biomedica SA
  • Chalice Medical Ltd
  • Dragerwerk AG & Co. KGaA
  • Estor SpA
  • Fresenius Medical Care AG
  • Getinge AB
  • Inspira-Technologies OXY BHN LTD
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medica SpA
  • MicroPort Scientific Corporation
  • Nikkiso Co., Ltd.
  • NovaLung GmbH
  • Spectrum Medical Ltd
  • Terumo Corporation
  • WEGO Group Co., Ltd.
  • X-COR Therapeutics
Product Code: MRR-F927BA462E0F

The Extracorporeal CO2 Removal Devices Market is projected to grow by USD 287.05 million at a CAGR of 8.73% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 159.68 million
Estimated Year [2026] USD 178.85 million
Forecast Year [2032] USD 287.05 million
CAGR (%) 8.73%

Extracorporeal CO2 removal devices are emerging as an important adjunct in advanced respiratory support, particularly for patients with acute hypercapnic respiratory failure, acute exacerbations of chronic obstructive pulmonary disease, and acute respiratory distress syndrome where conventional ventilation can contribute to lung injury. These systems remove carbon dioxide through an extracorporeal blood circuit using membrane gas exchange, enabling clinicians to reduce ventilatory intensity and support lung-protective or ultra-protective ventilation strategies. Clinical relevance is reinforced by the global burden of COPD, which the World Health Organization identifies as a leading cause of death worldwide, and by the continuing need to manage severe respiratory infections, refractory hypercapnia, and prolonged mechanical ventilation in intensive care units. The sector is shaped by rising clinical interest in lower-flow extracorporeal support, improvements in hemocompatible membranes, anticoagulation management, vascular access, and critical care workflow integration. Adoption remains highly dependent on trained multidisciplinary teams, reimbursement structures, safety evidence, and hospital infrastructure; however, extracorporeal carbon dioxide removal continues to attract attention as health systems seek more precise, less injurious respiratory support options for complex critical care populations.

Transformative Shifts in the Extracorporeal CO2 Removal Landscape

The extracorporeal CO2 removal devices landscape is being transformed by a shift from rescue-oriented extracorporeal support toward targeted respiratory management designed to reduce ventilator-associated lung injury. Device innovation is moving toward lower priming volumes, improved membrane oxygenator performance, simplified circuits, pressure and flow monitoring, and enhanced biocompatibility to reduce clotting, bleeding, hemolysis, and inflammatory complications. Clinical protocols are also evolving as intensive care units refine patient selection, timing of intervention, anticoagulation strategies, vascular access practices, escalation criteria, and weaning pathways. Another notable shift is the convergence of respiratory care, nephrology, perfusion, and extracorporeal life support expertise, as some platforms and care models align with familiar renal replacement therapy workflows. Regulatory scrutiny and evidence generation are becoming more rigorous, with hospitals demanding outcomes data, usability evidence, human factors validation, and clear risk-benefit profiles before broad deployment. At the same time, pandemic-era investments in critical care infrastructure have increased awareness of extracorporeal technologies, although adoption still varies widely by region, training availability, reimbursement support, and institutional experience.

Cumulative Impact of Artificial Intelligence on Extracorporeal CO2 Removal

Artificial intelligence is beginning to influence extracorporeal CO2 removal through decision support, device monitoring, predictive analytics, and workflow optimization rather than replacing clinician judgment. In critical care environments, AI-enabled models can help identify patients at risk of ventilator-induced lung injury, refractory hypercapnia, prolonged mechanical ventilation, or rapid acid-base deterioration by analyzing blood gases, ventilator settings, hemodynamics, laboratory trends, imaging outputs, and comorbidity profiles. When integrated with extracorporeal platforms and hospital information systems, advanced analytics may support earlier recognition of circuit clotting risk, membrane performance decline, anticoagulation instability, pressure changes, gas exchange inefficiency, or hemodynamic deterioration. AI can also enhance protocol adherence by flagging deviations in sweep gas settings, blood flow parameters, arterial carbon dioxide levels, acid-base status, and lung-protective ventilation targets. However, the cumulative impact depends on validated clinical datasets, interoperability, transparent algorithms, cybersecurity safeguards, clinician oversight, and careful mitigation of bias across diverse patient populations. The most immediate value is expected in augmenting intensivists, perfusionists, respiratory therapists, nephrologists, and nurses with real-time insights that improve safety, reduce cognitive burden, and standardize complex extracorporeal respiratory support practices.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa

Asia-Pacific is characterized by a substantial burden of chronic respiratory disease, dense urban populations exposed to air pollution, and expanding tertiary care infrastructure, creating strong clinical relevance for extracorporeal CO2 removal in advanced hospitals, particularly in China, Japan, South Korea, Australia, and India. North America benefits from mature intensive care networks, established extracorporeal life support expertise, academic critical care programs, and a regulatory environment that emphasizes safety evidence, quality systems, and clinical performance, supporting structured adoption in specialized centers. Latin America shows selective uptake concentrated in major metropolitan hospitals, where respiratory disease burden and critical care modernization coexist with constraints related to reimbursement, specialist training, biomedical engineering support, and access to disposable consumables. Europe is supported by strong critical care research networks, established respiratory medicine expertise, and harmonized medical device regulations that increase emphasis on clinical evaluation, post-market surveillance, risk management, and quality management. The Middle East is advancing through investment in high-acuity hospital infrastructure, medical tourism hubs, and government-backed healthcare modernization, with adoption most visible in advanced tertiary and quaternary care institutions. Africa remains highly heterogeneous, with limited access outside major referral centers; however, the growing burden of respiratory infections, COPD, tuberculosis-associated lung disease, and critical illness underscores the need for scalable training, biomedical engineering capability, oxygen and blood gas infrastructure, and reliable supply chains before extracorporeal CO2 removal can expand meaningfully.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

Within ASEAN, the relevance of extracorporeal CO2 removal is linked to increasing critical care investment, rising noncommunicable respiratory disease, persistent air quality challenges, and uneven access between advanced urban hospitals and resource-constrained settings. GCC countries are supported by high healthcare expenditure, modern hospital infrastructure, and strategic investment in specialized intensive care services, making the group comparatively well positioned for advanced extracorporeal respiratory support where trained multidisciplinary teams are available. The European Union provides a structured environment for device quality, clinical evidence, and cross-border research collaboration, with adoption shaped by medical device regulation, health technology assessment, procurement scrutiny, and hospital-level cost-effectiveness evaluation. BRICS countries combine large respiratory disease burdens with expanding tertiary care capacity, but adoption varies significantly due to differences in reimbursement, local manufacturing capability, specialist training, regulatory pathways, and public-sector procurement. G7 countries generally demonstrate stronger readiness because of advanced ICU infrastructure, established clinical research ecosystems, respiratory medicine expertise, and greater availability of multidisciplinary extracorporeal teams, although payer evaluation and safety evidence remain decisive. NATO member states overlap substantially with high-income healthcare systems and maintain advanced critical care capabilities, while emergency preparedness, trauma care, and military medicine priorities may further reinforce interest in portable, reliable, and rapidly deployable extracorporeal technologies for severe respiratory failure scenarios.

Key Country Insights Across Major Extracorporeal CO2 Removal Markets

The United States demonstrates strong relevance for extracorporeal CO2 removal due to its advanced critical care ecosystem, high COPD burden, large network of academic hospitals, and concentration of specialized centers experienced in extracorporeal life support, while Canada's adoption is influenced by publicly funded healthcare evaluation, regional referral networks, and emphasis on evidence-based ICU practice. Mexico and Brazil face significant respiratory disease burdens and growing tertiary care capabilities, but access is more concentrated in high-complexity hospitals where training, reimbursement, referral pathways, and consumable supply determine practical deployment. In Europe, the United Kingdom, Germany, France, Italy, and Spain have well-developed intensive care and respiratory medicine systems, with Germany and France particularly associated with strong hospital infrastructure and clinical research capacity, while the United Kingdom emphasizes guideline-driven adoption, national clinical governance, and health technology assessment. Russia has advanced tertiary medical centers capable of complex critical care, although geographic scale and uneven infrastructure influence availability. China is expanding critical care capacity rapidly and faces a large COPD and air pollution-related respiratory burden, creating strong clinical rationale in major hospitals; India combines a high respiratory disease burden with uneven ICU access, making affordability, training, and scalable service models critical. Japan, South Korea, and Australia have mature hospital systems, strong biomedical standards, experienced critical care communities, and established approaches to high-acuity respiratory support, supporting selective adoption in specialized settings where patient selection, anticoagulation management, and safety protocols are well established.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize robust clinical evidence, practical usability, and safety-centered design to accelerate responsible adoption of extracorporeal CO2 removal devices. Product development should focus on reducing bleeding and thrombosis risks, simplifying circuit setup, improving membrane durability, minimizing blood trauma, strengthening pressure and flow monitoring, and enabling integration with ICU information systems and ventilator data streams. Commercial strategies should be tailored to hospital readiness rather than broad deployment, targeting specialized intensive care centers with trained respiratory, perfusion, nephrology, vascular access, and extracorporeal life support teams. Education programs should include simulation-based training, anticoagulation protocols, cannulation and vascular access guidance, troubleshooting pathways, alarm management, and multidisciplinary competency frameworks. Leaders should also invest in real-world evidence registries, post-market surveillance, human factors studies, and interoperable data capture to demonstrate safety, clinical utility, and workflow value. In emerging regions, partnerships with hospitals, professional societies, and public health stakeholders can help address training gaps, maintenance capability, consumable availability, and supply-chain reliability. Clear positioning as an adjunct to lung-protective ventilation, rather than a universal replacement for conventional care, will support clinically credible messaging and sustainable adoption.

Research Methodology

The research methodology for evaluating extracorporeal CO2 removal devices relies on triangulation of verified secondary sources, clinical literature, regulatory documentation, hospital practice patterns, and expert-informed interpretation of critical care trends. Evidence inputs include peer-reviewed studies on extracorporeal carbon dioxide removal, respiratory failure management, COPD and ARDS care, mechanical ventilation strategies, anticoagulation complications, device safety, membrane gas exchange, and ICU workflow integration. Public health data from recognized national and international agencies are used to contextualize respiratory disease burden, critical care needs, air pollution exposure, demographic pressures, and regional healthcare capacity. Regulatory and standards-based sources inform analysis of device approval pathways, quality requirements, clinical evaluation expectations, risk management, usability engineering, and post-market responsibilities. Insights are validated by comparing findings across multiple source categories, including clinical guidelines, systematic reviews, registry-based observations, health system reports, medical technology policy documents, and critical care society publications. The methodology deliberately avoids market sizing, market share calculations, or forecasting and instead focuses on evidence-backed qualitative assessment of technology adoption drivers, barriers, regional readiness, and strategic implications for stakeholders.

Conclusion

Extracorporeal CO2 removal devices occupy a strategically important position in the evolution of advanced respiratory support, particularly as critical care teams seek to reduce ventilator-induced injury while managing severe hypercapnia and complex respiratory failure. The field is advancing through improvements in membrane technology, circuit design, monitoring, clinical protocols, vascular access, anticoagulation practice, and multidisciplinary training, while artificial intelligence offers additional potential to strengthen patient selection, safety surveillance, and operational consistency. Regional adoption is shaped less by disease burden alone and more by the availability of specialized ICU infrastructure, reimbursement clarity, regulatory confidence, reliable consumable supply, and experienced clinical teams. Countries and groups with established critical care networks are better positioned for selective implementation, while emerging settings require scalable training, service models, biomedical engineering support, and supply-chain resilience. For industry participants, long-term success will depend on generating credible clinical evidence, designing safer and simpler systems, and aligning technology with real-world intensive care workflows. As hospitals refine lung-protective strategies, extracorporeal CO2 removal is expected to remain a high-interest technology within precision critical care and advanced respiratory medicine.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Extracorporeal CO2 Removal Devices Market, by Product

  • 7.1. Introduction
  • 7.2. Membrane Lung Systems
    • 7.2.1. Low-Flow Cartridges
    • 7.2.2. High-Flux Cartridges
  • 7.3. Modular ECCO2R Kits
    • 7.3.1. Renal Platform Adapters
    • 7.3.2. ECMO Platform Adapters
  • 7.4. Control Consoles
  • 7.5. Disposable Treatment Sets

8. Extracorporeal CO2 Removal Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. Pump-Driven Venovenous
    • 8.2.1. Dual-Lumen Venous
    • 8.2.2. Single-Lumen Venous
  • 8.3. Arteriovenous Pumpless
  • 8.4. Hemodialysis-Based Removal
  • 8.5. Hybrid Gas Exchange

9. Extracorporeal CO2 Removal Devices Market, by Capacity Level

  • 9.1. Introduction
  • 9.2. Low-Flow Removal
  • 9.3. Moderate-Flow Removal
  • 9.4. High-Flow Removal

10. Extracorporeal CO2 Removal Devices Market, by Mode of Operation

  • 10.1. Introduction
  • 10.2. Automated Systems
  • 10.3. Manual Systems

11. Extracorporeal CO2 Removal Devices Market, by Application

  • 11.1. Introduction
  • 11.2. Acute Respiratory Distress Syndrome
  • 11.3. Bridge to Lung Transplant
  • 11.4. Chronic Obstructive Pulmonary Disease
  • 11.5. Postoperative Respiratory Support
  • 11.6. Hypercapnic Respiratory Failure

12. Extracorporeal CO2 Removal Devices Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Home Care Settings
  • 12.4. Hospitals
  • 12.5. Specialty Clinics

13. Extracorporeal CO2 Removal Devices Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Extracorporeal CO2 Removal Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal CO2 Removal Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Aferetica Srl
  • 17.2. Baxter International Inc.
  • 17.3. Braile Biomedica S.A.
  • 17.4. Chalice Medical Ltd
  • 17.5. Dragerwerk AG & Co. KGaA
  • 17.6. Estor S.p.A
  • 17.7. Fresenius Medical Care AG
  • 17.8. Getinge AB
  • 17.9. Inspira-Technologies OXY B.H.N. LTD
  • 17.10. Koninklijke Philips N.V.
  • 17.11. LivaNova PLC
  • 17.12. Medica S.p.A
  • 17.13. MicroPort Scientific Corporation
  • 17.14. Nikkiso Co., Ltd.
  • 17.15. NovaLung GmbH
  • 17.16. Spectrum Medical Ltd
  • 17.17. Terumo Corporation
  • 17.18. WEGO Group Co., Ltd.
  • 17.19. X-COR Therapeutics

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEMBRANE LUNG SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEMBRANE LUNG SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEMBRANE LUNG SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LOW-FLOW CARTRIDGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LOW-FLOW CARTRIDGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LOW-FLOW CARTRIDGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-FLUX CARTRIDGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-FLUX CARTRIDGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-FLUX CARTRIDGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MODULAR ECCO2R KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MODULAR ECCO2R KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MODULAR ECCO2R KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RENAL PLATFORM ADAPTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RENAL PLATFORM ADAPTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RENAL PLATFORM ADAPTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ECMO PLATFORM ADAPTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ECMO PLATFORM ADAPTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ECMO PLATFORM ADAPTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONTROL CONSOLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTROL CONSOLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONTROL CONSOLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DISPOSABLE TREATMENT SETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DISPOSABLE TREATMENT SETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DISPOSABLE TREATMENT SETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PUMP-DRIVEN VENOVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PUMP-DRIVEN VENOVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PUMP-DRIVEN VENOVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DUAL-LUMEN VENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DUAL-LUMEN VENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DUAL-LUMEN VENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE-LUMEN VENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE-LUMEN VENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE-LUMEN VENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTERIOVENOUS PUMPLESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTERIOVENOUS PUMPLESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTERIOVENOUS PUMPLESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEMODIALYSIS-BASED REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEMODIALYSIS-BASED REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEMODIALYSIS-BASED REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HYBRID GAS EXCHANGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HYBRID GAS EXCHANGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HYBRID GAS EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LOW-FLOW REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LOW-FLOW REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LOW-FLOW REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MODERATE-FLOW REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MODERATE-FLOW REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MODERATE-FLOW REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIGH-FLOW REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIGH-FLOW REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIGH-FLOW REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MANUAL SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MANUAL SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MANUAL SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRIDGE TO LUNG TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRIDGE TO LUNG TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRIDGE TO LUNG TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POSTOPERATIVE RESPIRATORY SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL POSTOPERATIVE RESPIRATORY SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POSTOPERATIVE RESPIRATORY SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HYPERCAPNIC RESPIRATORY FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HYPERCAPNIC RESPIRATORY FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HYPERCAPNIC RESPIRATORY FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 167. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 172. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 173. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 197. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 201. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 202. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 203. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 209. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 211. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 212. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 213. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 228. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 230. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 232. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 238. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 239. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 240. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 242. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 248. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 249. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 250. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 268. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 269. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 270. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 272. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 274. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 278. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 279. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 280. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 282. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 283. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 284. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 288. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 289. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 290. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 292. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 293. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 294. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 298. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 299. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 300. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 301. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 302. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 303. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 304. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 305. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 308. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 309. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
  • TABLE 310. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
  • TABLE 312. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 313. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 314. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE